NCT05943652 Observational Study on "Functional Overlay" in Patients With Movement Disorders
| NCT ID | NCT05943652 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Graz |
| Condition | Conversion Disorder |
| Study Type | OBSERVATIONAL |
| Enrollment | 216 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 216 participants in total. It began in 2023-01-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about functional neurological disorders in patients with common non-functional movement disorders ("functional overlay"). The main questions it aims to answer are: * What is the frequency of functional neurological disorders in patients with non-functional movement disorders (functional overlay)? * What are the characteristics of functional neurological disorders in patients with non-functional movement disorders? Participants will be examined clinically and electrophysiologically, the examinations consist of: * a neurological examination * neuropsychological testing * electrophysiological tremor diagnostic * questionnaires about psychological, biological and social risk factors Researchers will compare patients with functional motor disorders to patients wit non-functional movement disorders to see if they differ from each other regarding the functional symptoms.
Eligibility Criteria
Inclusion Criteria: * Functional or non-functional movement disorder * 18 to 80 years Exclusion Criteria: * Patient is not able to consent * Patient is not able to understand / speak German fluently (questionnaires are available only in German)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05943652 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 18 Years, studying Conversion Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05943652 currently recruiting?
Yes, NCT05943652 is actively recruiting participants. Contact the research team at daniela.eibl@medunigraz.at for enrollment information.
Where is the NCT05943652 trial being conducted?
This trial is being conducted at Graz, Austria.
Who is sponsoring the NCT05943652 clinical trial?
NCT05943652 is sponsored by Medical University of Graz. The trial plans to enroll 216 participants.